Inovio Pharmaceuticals (INO) Stock Price, Quote, News & History | Benzinga

Inovio Pharmaceuticals Inc (INO) Stock Price, Quote, News & History

INONASDAQ

Trade with Public

Trade with Public

$1.09

0.1921.1%

At close: Aug 14, 5:00 PM EST

$1.08

-0.01-0.92%

After Hours: Aug 14, 7:59 PM EST

Earnings: Q2 2026 Earnings were released on Wed Aug 12th, after the market close

Conference Call: The most recent conference call started at 4:30 PM, 4 days ago

Click to view the webcast

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Compare Options Stock Report

Key Statistics

Open

$0.93

Close

$1.09

Volume / Avg.

12.21M / 2.89M

Day Range

$0.90 - $1.10

52 Wk Range

0.56 - 2.98

Market Cap

$111.67M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

62

Short Interest

17.21%

Days to Cover

3.13

Recent Inovio Pharmaceuticals Inc News

Nasdaq Surges Over 600 Points; Microsoft Shares Jump After Upbeat Q4 Results

US stocks rise with Nasdaq up 600 points, Dow up 0.69% and S&P 500 up 1.29%. Tech shares up 5%, communication services down 3.3%. Microsoft jumps 15% after strong earnings.

Avi Kapoor

Why Microsoft Shares Are Trading Higher By 8%; Here Are 20 Stocks Moving Premarket

Microsoft (NASDAQ: MSFT) reported strong Q4 results, beating revenue and earnings estimates. Shares jumped 7.8% in pre-market trading.

Avi Kapoor

Inovio Stock Falls 21% After Hours: Here's What's Going On

Inovio stock fell after hours after pricing a $20 million public offering of common stock and warrants.

Tanya Rawat

What's Going On With Inovio Pharmaceuticals Stock On Tuesday?

Inovio prices a $17.5 million share offering, narrows losses, cuts expenses, and advances INO-3107 under FDA review.

Vandana Singh

What's Behind The Drop In Inovio Pharmaceuticals Stock Today?

Inovio Pharmaceuticals, Inc. (NASDAQ:INO) shares are tumbling Thursday after the company announced the pricing of a proposed public offering.

Alex Perry

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-80.58M

Investing Cash Flow (TTM)

17.59M

Financing Cash Flow (TTM)

70.17M

Free Cash Flow (TTM)

-80.78M

Capital Expenditure (TTM)

-

Net Change in Cash (TTM)

7.17M

Analyst Trends and Forecast

1

Jun

2

Aug

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.9

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$84.03M

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

-

PB Ratio (TTM)

22.04

Earnings Yield % (TTM)

-110.56%

Earnings Yield % (FWD)

-108.42%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$0.04

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$31.53M

Debt to Equity

1.83

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

-

Key Statistics

Open

$0.93

Close

$1.09

Volume / Avg.

12.21M / 2.89M

Day Range

$0.90 - $1.10

52 Wk Range

0.56 - 2.98

Market Cap

$111.67M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

62

Short Interest

17.21%

Days to Cover

3.13

About

Sector

Health Care

Industry

Biotechnology

Inovio Pharmaceuticals Inc is a clinical-stage biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from diseases associated with human papillomavirus (HPV), cancer and infectious diseases. IN...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy Inovio Pharmaceuticals (INO) stock?

A

You can purchase shares of Inovio Pharmaceuticals (NASDAQ:INO) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Inovio Pharmaceuticals (INO) competitors?

A

Other companies in Inovio Pharmaceuticals’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).

Q

What is the forecast, or price target, for Inovio Pharmaceuticals (INO) stock?

A

Inovio Pharmaceuticals has a consensus price target of $13.72.

Q

What is the current price for Inovio Pharmaceuticals (INO)?

A

The stock price for Inovio Pharmaceuticals (NASDAQ: INO) is $1.08 last updated August 14, 2026 at 7:59 PM EDT.

Q

Does Inovio Pharmaceuticals (INO) pay a dividend?

A

There are no upcoming dividends for Inovio Pharmaceuticals.

Q

When is Inovio Pharmaceuticals (NASDAQ:INO) reporting earnings?

A

Inovio Pharmaceuticals does not have any upcoming earnings scheduled.

Q

Is Inovio Pharmaceuticals (INO) going to split?

A

There is no upcoming split for Inovio Pharmaceuticals.

Q

What sector and industry does Inovio Pharmaceuticals (INO) operate in?

A

Inovio Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.